As the first step in the decommissioning of the site has been converted to read-only mode.

Here are some tips for How to share your SAS knowledge with your professional network.

Call For GPP Steering Board Members

From sasCommunity
Jump to: navigation, search

Good Programming Practice for Clinical Trials (GPP)

Call for Volunteers– Update May 2010: New members now appointed

GPP is currently seeking volunteers interested in joining the Steering Board. Board participation is open to all statistical and clinical data programmers and statisticians who have been programming for at least five years and have direct experience in clinical trials research. Approval to join the Steering Board will be granted by the existing GPP Board. Accepted applicants will be notified of their appointments on or before May 7th, 2010 by email.

The application will close on Friday, April 23rd. For more information, visit our page on Good Programming Practice for Clinical Trials. You will be actively involved in leading a key global industry initiative. Volunteering is also an excellent opportunity for professional development, networking and active engagement within the programming community and the BioPharma Industry.

Apply Today! To apply or if you have questions please contact Mark Foxwell, or Louise Webber,

About GPP We are a volunteer organization focused on developing and documenting Good Programming Practice for Clinical Research, working with regulatory agencies, the standards institutes, and professional associations within the BioPharma Industry. The aim is to encourage contributions from across companies, non-profit organizations and regulators in an attempt to create a consensus recommendation. The ambition is that this work becomes recognized by the BioPharma Industry as well as Regulatory Authorities. Our objective is to facilitate sharing of best practice for programmers in clinical research. We intend to develop publicly available guidance that addresses all relevant aspects of programming. We have recently begun to engage the U.S. Food and Drug Administration, professional associations, and pharmaceutical companies in our draft work to ensure we have the appropriate level of buy-in from regulators. As a Board member you will be actively contributing and will have specific areas of responsibility.